CBI Annual Combination Drug Therpies, Philadelphia, PA, USA
Event Apr 26
CBI’s 2nd Annual Combination Drug Therapies event offers information on preclinical and clinical guidelines for developing combination studies. Hear case studies providing information on new combinations, treatment guidelines and protocol designs of combination drug therapy studies.
·Regulatory and safety issues of combination drug therapies
·Patent issues regarding combination studies
·Preclinical development requirements
·Developments of novel combination therapies
·Combination of drugs across indications
Confirmed Speakers Include:-
AstraZeneca, CombinatoRx, Incorporated, Creighton University School of Medicine, Eastern Virginia Medical School, Eli Lilly and Company, Gene Network Sciences, GlaxoSmithKline Pharmaceuticals.
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018